Composition Strengths

150 mg single-dose, 150 mg multi-dose and 440 mg multi-dose vials containing powder for concentrate for solution for TM intravenous infusion. Reconstituted Hertraz concentrate contains approximately 21 mg/mL of trastuzumab, a humanised IgG1 monoclonal antibody expressed in Chinese hamster ovary cell suspension culture, and purified by affinity and ionexchange chromatography including specific viral inactivation and removal procedures.

Dosage Form

Powder for concentrate for solution for infusion.TM Hertraz a white to pale yellow lyophilised powder. Hertraz™ reconstituted with BWFI, as supplied, is stable for 28 days after reconstitution when stored refrigerated at 2°C-8°C (36ºF-46°F).

Pack size

Available in 440-mg and 150-mg multidose vials

Hotline: 028 9999 25 75